Neoantigen-Based Immunotherapy for a Long-Term Survivor With Pancreatic Neuroendocrine Tumor

Pancreas. 2022 Aug 1;51(7):e99-e101. doi: 10.1097/MPA.0000000000002092.
No abstract available

MeSH terms

  • Humans
  • Immunotherapy
  • Neuroendocrine Tumors* / therapy
  • Pancreatic Neoplasms* / therapy
  • Survivors